About National Hospital Organization Kyushu Cancer Center
独立行政法人国立病院機構九州がんセンターは、福岡県福岡市南区野多目にある医療機関。独立行政法人国立病院機構が運営する病院である。がん専門病院であり、がん政策医療ネットワークの基幹医療施設である。福岡県の都道府県がん診療連携拠点病院に指定されている。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at National Hospital Organization Kyushu Cancer Center
During the past decade, National Hospital Organization Kyushu Cancer Center conducted 61 clinical trials. In the 10-year time frame, 61 clinical trials started and 33 clinical trials were completed, i.e. on
average, 54.1% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 19 clinical trials were completed. i.e. 86.4%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "National Hospital Organization Kyushu Cancer Center" #1 sponsor was "Pfizer" with 20 trials, followed by "Hoffmann-La Roche" with 14 trials
sponsored, "Daiichi Sankyo, Inc." with 9 trials sponsored, "Daiichi Sankyo Co., Ltd." with 5 trials sponsored and "Incyte Corporation"
with 5 trials sponsored. Other sponsors include 19 different institutions and
companies that sponsored additional 23 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Kyushu Cancer Center"
#1 collaborator was "AstraZeneca" with 10 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 5 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator and "Japan Lung Cancer Society" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were
collaborators in the rest 24 trials.
Clinical Trials Conditions at National Hospital Organization Kyushu Cancer Center
According to Clinical.Site data, the most researched conditions in "National Hospital Organization Kyushu Cancer Center" are
"Breast Cancer" (9 trials), "Breast Neoplasms" (5 trials), "Non-Small Cell Lung Cancer" (5 trials), "Lymphoma" (3 trials) and "Non Small Cell Lung Cancer" (3 trials). Many other conditions were trialed in "National Hospital Organization Kyushu Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at National Hospital Organization Kyushu Cancer Center
Most popular intervention types in "National Hospital Organization Kyushu Cancer Center" are "Drug" (74 trials), "Biological" (2 trials), "Other" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Gemcitabine" (8 trials), "Carboplatin" (7 trials), "Paclitaxel" (7 trials) and "Cisplatin" (6 trials). Other intervention names were less common.
Clinical Trials Genders at National Hospital Organization Kyushu Cancer Center
The vast majority of trials in "National Hospital Organization Kyushu Cancer Center" are
69 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at National Hospital Organization Kyushu Cancer Center
Currently, there are NaN active trials in "National Hospital Organization Kyushu Cancer Center".
undefined are not yet recruiting,
13 are recruiting,
30 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 30 completed trials in National Hospital Organization Kyushu Cancer Center,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in National Hospital Organization Kyushu Cancer Center, 12 "Phase 1"
clinical trials were conducted, 28 "Phase 2" clinical
trials and 37 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".